NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma

Publication Date

2023

Content Type

Article

PubMed ID:

36260832

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS